Hepatitis C virus co-infection increases the risk of anti-tuberculosis drug-induced hepatotoxicity among patients with pulmonary tuberculosis.

Hepatitis C virus co-infection increases the risk of anti-tuberculosis drug-induced hepatotoxicity among patients with pulmonary tuberculosis.

The country of Georgia has a high prevalence of tuberculosis (TB) and hepatitis C virus (HCV) infection.To determine whether HCV co-infection increases the risk of incident drug-induced hepatitis among patients on first-line anti-TB drug therapy.Prospective cohort study; HCV serology was obtained on...

Full description

Bibliographic Details
Main Authors: Nino Lomtadze, Lali Kupreishvili, Archil Salakaia, Sergo Vashakidze, Lali Sharvadze, Russell R Kempker, Matthew J Magee, Carlos del Rio, Henry M Blumberg
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3868578?pdf=render

Internet

http://europepmc.org/articles/PMC3868578?pdf=render

Similar Items